SPONSOR
Regina Elena Cancer Institute
Total Trials
5
Recruiting
5
Phases
N/A
Conditions studied: Breast Neoplasms, MaleBladder CancerLocalized Prostate CancerAdvanced Non-small Cell Lung Cancer (NSCLC)Endometrial Cancer
Regina Elena Cancer Institute is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Breast Neoplasms, Male, Bladder Cancer, Localized Prostate Cancer, Advanced Non-small Cell Lung Cancer (NSCLC).
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Regina Elena Cancer Institute
How many clinical trials has Regina Elena Cancer Institute sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Regina Elena Cancer Institute, of which 5 are actively recruiting participants. These trials cover conditions including Breast Neoplasms, Male, Bladder Cancer, Localized Prostate Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Regina Elena Cancer Institute research focus on?
Regina Elena Cancer Institute clinical trials span Breast Neoplasms, Male, Bladder Cancer, Localized Prostate Cancer, Advanced Non-small Cell Lung Cancer (NSCLC), Endometrial Cancer. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Regina Elena Cancer Institute clinical trial?
To participate in a Regina Elena Cancer Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Regina Elena Cancer Institute trials with current recruitment status updated daily.
Clinical Trials by Regina Elena Cancer Institute
NCT06786663
Recruiting
MALE Mamm Organoids
Breast Neoplasms, Male
NCT06992986
Recruiting
Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population
Bladder Cancer
NCT07792993
Recruiting
Focal Micro-boost Strategy in Patients With Intermediate- to High-risk Prostate Cancer (IR-HR PCa) Undergoing Hypofractionated Radiotherapy
Localized Prostate Cancer
NCT07649629
Recruiting
Impact of Liquid Biopsy on the Therapeutic Pathway for Lung Cancer: Advancing the Molecular Characterization of Patients With Advanced Lung Adenocarcinoma by Integrating Liquid Biopsy Into the Early Stages of the Diagnostic and Therapeutic Pathway
Advanced Non-small Cell Lung Cancer (NSCLC)
NCT07258186
Recruiting
Generation of Endometrial Carcinoma Organoids
Endometrial Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology